Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
49.8M
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
41.9M
-
Shares change
-
+6.01M
-
Total reported value, excl. options
-
$1.88B
-
Value change
-
+$275M
-
Put/Call ratio
-
0.38
-
Number of buys
-
113
-
Number of sells
-
-58
-
Price
-
$44.95
Significant Holders of AtriCure, Inc. - Common Shares (ATRC) as of Q2 2020
204 filings reported holding ATRC - AtriCure, Inc. - Common Shares as of Q2 2020.
AtriCure, Inc. - Common Shares (ATRC) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.9M shares
of 49.8M outstanding shares and own 84.1% of the company stock.
Largest 10 shareholders include FMR LLC (4.77M shares), BlackRock Inc. (3.4M shares), FRED ALGER MANAGEMENT, LLC (2.3M shares), VANGUARD GROUP INC (2.27M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.23M shares), Invesco Ltd. (1.77M shares), Champlain Investment Partners, LLC (1.66M shares), ORBIMED ADVISORS LLC (1.23M shares), TimesSquare Capital Management, LLC (1.18M shares), and GILDER GAGNON HOWE & CO LLC (1.03M shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.